MHRA statement on new review of paracetamol safety during pregnancy

List of Field Safety Notices from 3 to 7 November 2025.

Guidance on the MHRA’s national assessment procedure for marketing authorisation applications.

This guidance clarifies the expectations on the application of the further pharmacovigilance provisions set out within the updated CIR 520/2012 for UK authorised products.

The MMRV vaccine will become part of the routine childhood immunisation schedule in the UK from 1 January 2026.  

MHRA opens second round of applications to test cutting-edge AI medical technologies following successful pilot phase.

List of Field Safety Notices from 7 to 11 July 2025.